
Early Alzheimer’s Study
The purpose of this early Alzheimer's study is to find out if the study drug can possibly prevent, delay, or slow early symptoms of Alzheimer’s disease.
Preliminary Qualifications
-
You are 55–85 years of age.
-
You have a diagnosis of mild- to moderate-Alzheimer's disease.
-
You can swallow capsules